Principal Financial Group Inc. raised its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 6.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,116,766 shares of the company's stock after purchasing an additional 235,316 shares during the period. Principal Financial Group Inc. owned approximately 1.08% of LifeStance Health Group worth $28,817,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Point72 Asset Management L.P. acquired a new stake in shares of LifeStance Health Group during the 2nd quarter worth approximately $4,326,000. Dimensional Fund Advisors LP increased its position in shares of LifeStance Health Group by 82.0% during the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company's stock worth $4,991,000 after buying an additional 457,930 shares during the period. Magnetar Financial LLC bought a new position in shares of LifeStance Health Group in the 2nd quarter worth about $762,000. TD Asset Management Inc acquired a new position in LifeStance Health Group in the second quarter valued at approximately $623,000. Finally, Sei Investments Co. bought a new position in LifeStance Health Group during the second quarter worth $477,000. 85.50% of the stock is currently owned by institutional investors.
LifeStance Health Group Trading Down 2.7 %
Shares of LFST traded down $0.20 during trading hours on Wednesday, hitting $7.20. The company's stock had a trading volume of 2,718,877 shares, compared to its average volume of 1,513,207. The business has a 50 day simple moving average of $6.96 and a two-hundred day simple moving average of $6.22. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.22. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $9.20.
LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.05. The firm had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The company's revenue for the quarter was up 18.9% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.17) earnings per share. As a group, equities research analysts anticipate that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current fiscal year.
Insider Transactions at LifeStance Health Group
In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of LifeStance Health Group stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total transaction of $33,089.32. Following the sale, the insider now directly owns 263,007 shares of the company's stock, valued at approximately $1,651,683.96. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 6.60% of the company's stock.
Analyst Ratings Changes
A number of equities analysts recently issued reports on LFST shares. Barclays increased their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a report on Monday. UBS Group lowered their target price on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating on the stock in a research note on Thursday, August 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $8.42.
Check Out Our Latest Analysis on LFST
About LifeStance Health Group
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
